NCT06900088 2025-03-28Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms PatientsInstitute of Hematology & Blood Diseases Hospital, ChinaPhase 2 Not yet recruiting20 enrolled